IG Funding

New: ERDERA Clinical Trial Call 2026
The CIHR Institute of Genetics is participating in the upcoming ERDERA Clinical Trial Call 2026 (ECTC 2026), led by the European Rare Diseases Research Alliance. This funding opportunity will support multinational, GCP-compliant Phase I, Phase I/II, and Phase II interventional clinical trials in rare diseases. Further details are available on the ERDERA website.

Linkage tool
Annex IV. Guidelines for Canadian Applicants

The Institute of Genetics (IG) funds health research in order to develop and support a well-trained base of investigators with the skills and expertise needed to design and conduct innovative and diverse research and knowledge translation activities aimed at improving health.

Find out more about IG's funding:

Opportunities
Decisions
Maud Menten New Principal Investigator Prizes in Genetics

Date modified:: 2026-07-10

Language selection

Search and menus

Search

IG Funding